Pacific Biosciences (PACB): Assessing Valuation After SPRQ-Nx Launch and Landmark Genomics Project Wins [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
The launch aims to lower genome sequencing costs and appeal to a broader customer base with new multiomic and regulatory capabilities. See our latest analysis for Pacific Biosciences of California. It has been a whirlwind of headlines for Pacific Biosciences recently, from unveiling cost-cutting genome chemistry to being chosen for landmark national projects in Korea and the US. Despite this spike in commercial momentum and technological upgrades, the stock's 1-month share price return stands at an impressive 33.3%, yet the 1-year total shareholder return lags at -17.2%. This reflects both renewed excitement and the challenges the company is still working to overcome. If these rapid developments have you curious about where else innovation is driving opportunity, now is a great time to discover See the full list for free. With PacBio's shares rebounding sharply yet still trading well below their historical highs, investors face a classic dilemma. Does the current valuation off
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment [Yahoo! Finance]Yahoo! Finance
- Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 11/5/25 - Beat
PACB
Analyst Actions
- 11/10/25 - Stephens & Co.
PACB
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PACB's page on the SEC website